Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status

被引：11
作者：
Baumann, Pierre [1 ]
Barbe, Remy
Vabre-Bogdalova, Assia
Garran, Encarni
Crettol, Severine
Eap, Chin B.
机构：
[1] CHU Vaudois, Dept Psychiat, Ctr Neurosci Psychiat, Unite Biochim, Prilly, Switzerland
[2] CHU Vaudois, Dept Psychiat, Ctr Neurosci Psychiat, Psychopharmacol Clin, Prilly, Switzerland
[3] State Univ Ghent Hosp, Dept Psychiat, Serv Psychiat Enfant & Adolescent, Geneva, Switzerland
[4] Serv Medicopedag, Unite Adolescents, Geneva, Switzerland
[5] Ctr Medicopsychol Enfants, Delemont, Switzerland
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2006年 / 26卷 / 06期
关键词：
RANDOMIZED CONTROLLED-TRIAL; HUMAN LIVER-MICROSOMES; N-DEMETHYLATION; PLASMA-LEVELS; IN-VITRO; PHARMACOKINETICS; CHILDREN; METABOLIZERS; VARIABILITY; BUPROPION;
D O I：
10.1097/01.jcp.0000239795.14202.c3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：679 / 681
页数：3
相关论文
共 26 条
  • [1] Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability and efficacy
    Alderman, J
    Wolkow, R
    Chung, M
    Johnston, HF
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1998, 37 (04) : 386 - 394
  • [2] Sertraline pharmacokinetics and dynamics in adolescents
    Axelson, DA
    Perel, JM
    Birmaher, B
    Rudolph, GR
    Nuss, S
    Bridge, J
    Brent, DA
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (09) : 1037 - 1044
  • [3] DEXTROMETHORPHAN AND MEPHENYTOIN PHENOTYPING OF PATIENTS TREATED WITH THIORIDAZINE OR AMITRIPTYLINE
    BAUMANN, P
    MEYER, JW
    AMEY, M
    BAETTIG, D
    BRYOIS, C
    JONZIERPEREY, M
    KOEB, L
    MONNEY, C
    WOGGON, B
    [J]. THERAPEUTIC DRUG MONITORING, 1992, 14 (01) : 1 - 8
  • [4] The AGNP-TDM expert group consensus guidelines:: Therapeutic Drug Monitoring in psychiatry
    Baumann, P
    Hiemke, C
    Ulrich, S
    Eckermann, G
    Gaertner, I
    Gerlach, M
    Kuss, HJ
    Laux, G
    Müller-Oerlinghausen, B
    Rao, ML
    Riederer, P
    Zernig, G
    [J]. PHARMACOPSYCHIATRY, 2004, 37 (06) : 243 - 265
  • [5] Olanzapine - An updated review of its use in the management of schizophrenia
    Bhana, N
    Foster, RH
    Olney, R
    Plosker, GL
    [J]. DRUGS, 2001, 61 (01) : 111 - 161
  • [6] Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder
    Cook, EH
    Wagner, KD
    March, JS
    Biederman, J
    Landau, P
    Wolkow, R
    Messig, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2001, 40 (10) : 1175 - 1181
  • [7] Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
    Crettol, S
    Déglon, JJ
    Besson, J
    Croquette-Krokkar, M
    Gothuey, I
    Hämmig, R
    Monnat, M
    Hüttemann, H
    Baumann, P
    Eap, CB
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (06) : 593 - 604
  • [8] Clinical pharmacokinetics of sertraline
    DeVane, CL
    Liston, HL
    Markowitz, JS
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (15) : 1247 - 1266
  • [9] Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects
    Eap, CB
    Buclin, T
    Hustert, E
    Bleiber, G
    Golay, KP
    Aubert, AC
    Baumann, P
    Telenti, A
    Kerb, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (04) : 231 - 236
  • [10] Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity
    Eap, CB
    Buclin, T
    Cucchia, G
    Zullino, D
    Hustert, E
    Bleiber, G
    Golay, KP
    Aubert, AC
    Baumann, P
    Telenti, A
    Kerb, R
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 60 (04) : 237 - 246
123